June 6, 2024

Applying the 2024 ADA standards of care into practice: a practical approach to basal insulin in Type 2 diabetes

In this special sponsored episode from Sanofi, we welcome Jennifer Goldman. She is a professor of pharmacy at the Massachusetts College of Pharmacy and Health Sciences, board-certified in advanced diabetes management, and a certified diabetes care and...

In this special sponsored episode from Sanofi, we welcome Jennifer Goldman. She is a professor of pharmacy at the Massachusetts College of Pharmacy and Health Sciences, board-certified in advanced diabetes management, and a certified diabetes care and education specialist.

Together, we delve into the latest insights from the American Diabetes Association (ADA) guidelines, exploring topics such as intensifying injectable therapies and the pivotal role of basal insulin in Type 2 diabetes management. Jennifer provides expert guidance on identifying candidates for basal insulin therapy, managing severe hyperglycemia, and initiating basal insulin treatment in patients new to therapy. Additionally, she discusses the differences between basal insulin analogs and offers practical strategies for overcoming common challenges associated with basal insulin therapy.

Connect with us in the coming weeks on LinkedIn (http://www.linkedin.com/in/kevinmd) and X (https://twitter.com/kevinmd) for the next part of this series, where you can learn more about the different types of basal insulin analogs to manage Type 2 diabetes.

Disclosures

  • This program is non-promotional and sponsored by Sanofi.
  • Speakers are being compensated and/or receiving an honorarium from Sanofi in connection with this presentation.
  • The content contained in this presentation was jointly developed by speakers and Sanofi.
  • The program is not eligible for continuing medical education (CME) credits.

Important information

These materials aim to outline common clinical considerations and procedural steps for using referenced products. However, they may not be suitable for every patient or case. Results may vary. Results from one case study are not necessarily predictive of results in other cases.  Decisions regarding patient care rely on the physician's professional judgment, taking into account all available information for the individual case.

Sanofi does not endorse or advocate for the use of its products beyond their FDA-approved labeling. We do not offer medical advice, diagnosis, or treatment. The health information provided herein is for general educational purposes only. Your health care professional remains the primary source of information regarding your health. Please consult your health care professional if you have any questions about your health or treatment.

Intended for residents of the United States only.

VISIT SPONSOR → https://www.sanofi.com/

SUBSCRIBE TO THE PODCAST → https://www.kevinmd.com/podcast